BD Welcomes Gregory J. Hayes to Its Board of Directors Amid Strategic Evolution

In a significant move for the company, BD (Becton, Dickinson and Company) has announced the appointment of Gregory J. Hayes to its Board of Directors, effective March 26, 2025. As a pioneer in the medical technology field, BD continues to position itself as a leader in the industry, and with Hayes' addition, the board is further strengthened by his extensive experience.

At 64, Hayes is currently the executive chairman of RTX Corporation, the world’s largest aerospace and defense firm. His career spans over 30 years, during which he has held numerous senior leadership roles, including that of CEO at United Technologies Corporation (UTC). Under his leadership, UTC thrived through transformative initiatives, including significant mergers, acquisitions, and strategic business development, showcasing his ability to navigate complex corporate landscapes.

Tom Polen, Chairman, CEO, and President of BD, expressed enthusiasm about Hayes' arrival: “Greg will join the board at a pivotal time in BD's transformation as we seek to unlock significant shareholder value.” Polen highlighted that Hayes’ proven track record in portfolio optimization and driving operational efficiencies is aligned with BD’s commitment to achieving excellence and continuous improvement.

Strategic Transformation: The 'New BD' Initiative

As BD embarks on a transformative journey, the introduction of the 'New BD' signifies a clear vision for the company's future. This initiative includes the planned separation of their Diagnostic Solutions and Biosciences business, a strategic decision that underscores BD's commitment to broadening its focus and enhancing innovation. Polen reiterated that Hayes would be an invaluable asset during this pivotal period, helping guide BD towards becoming a more focused player in the medtech space.

“BD has a remarkable 125-year history as a leading manufacturer of medical devices,” Hayes stated, emphasizing the company’s critical role in the healthcare infrastructure. He shared his excitement for the upcoming opportunities and recognized the fantastic potential BD has to enhance clinical therapy through innovation. Hayes' strategic leadership is expected to foster profitable growth and sustainable value for all stakeholders involved.

Hayes' Track Record of Excellence

Before joining RTX, Hayes had a long-standing career at UTC, where he made a significant impact on the company’s strategic direction, culminating in his appointment as CEO in 2014. His vision was pivotal during the formation of RTX from the merger of UTC’s aerospace arms—Pratt Whitney and Collins Aerospace—with Raytheon. This kind of innovative thinking and capability to merge large entities will be crucial as BD pushes ahead with its plans for growth and operational excellence.

Hayes is not a stranger to board responsibilities; he currently serves on the board of Phillips 66 Company, further broadening his insights into corporate governance and leading firms across various industries.

A Commitment to Healthcare Advancement

Through his collaborative efforts with the board and executive teams, Hayes aims to drive BD towards a future marked by enhanced innovation and efficiency. His academic background, including a bachelor's degree in Economics from Purdue University, along with his status as a certified public accountant, adds depth to his executive capabilities.

BD's commitment remains steadfast, fostering a culture that supports the heroes on the frontlines of healthcare. As one of the largest global medical technology entities, BD dedicates itself to improving medical discovery and diagnostics through innovative technologies and solutions that boost clinical capabilities for healthcare providers.

As BD navigates this transformative phase with Gregory J. Hayes now at the helm of its Board of Directors, the company is poised to maintain its leadership status in the medical technology field, promising exciting advancements and opportunities for shareholders and stakeholders alike. For further details about BD and its initiatives, explore their official website or connect through their social media channels.